Alfa Chemistry Materials Announces a New Product Offering of Quantum Dots

LIQUID STABLE, MATRIX PLUS™ CHEMISTRY REFERENCE MATERIALS NOW OFFERED BY VERICHEM LABORATORIES

Verichem’s MATRIX PLUS™ Chemistry Reference Kit is expressly intended to support overall system QC and CLIA compliance within the clinical laboratory.

FDS Amplicare Awards $25,000 Grant to CPESN Minnesota to Help 50 Community Pharmacies Expand Healthcare Services

FDS Amplicare Awards $25,000 Grant to CPESN Minnesota to Help 50 Community Pharmacies Expand Healthcare Services

Protheragen MedAI Fully Supports In Vitro Pharmacology Research for Drug Discovery

Flywheel and HealthMyne Partner to Provide End-to-End Radiomic Data Management and Analysis

Flywheel and HealthMyne: Combined technology solution to accelerate radiomics research and clinical trial outcomes

Standigm Secures Strategic Investment from SK Chemicals for Expanding its AI-Drug Development Capacity

Standigm Inc. (“Standigm”), a leading workflow artificial intelligence (AI) drug discovery company, and SK Chemicals Co., Ltd (“SK Chemicals”), a life science and green chemicals company, announced today that they have signed a strategic partnership contract for collaboration regarding clinical development of Standigm’s AI-driven drug candidate for non-alcoholic steatohepatitis (“NASH”) and the foundation of Standigm’s Synthesis Research Center within the headquarters of SK Chemicals. This partnership was made in conjunction with SK Chemicals’ participation in Standigm’s pre-IPO round of fundraising.

New Cotiviti Research Captures Healthcare Payer Shift from Postpay to Prepay Claim Integrity

Survey of >100 health plan leaders offers insight into the challenges of balancing prospective and retrospective approaches across enterprise payment integrity programs

VERICHEM LABORATORIES EXPANDS LINE OF BIO-SYNTHETIC CLINICAL REFERENCE MATERIALS FOR URINE CHEMISTRIES

VERICHEM now offers clinical laboratorians an extensive line of liquid stable and ready-to-use biosynthetic clinical reference materials for urine chemistry assays.

Genezen breaks ground on cGMP lentiviral vector production facility

Genezen Laboratories, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production and analytical testing services, has broken ground on a new multiphase master plan for a 75,000+ square foot cGMP-compliant Lentiviral vector production facility.

ZEISS revolutionizes quantitative petrography

ZEISS introduces unique digitization system for virtual microscopy, collaboration and machine learning data analytics

Protheragen MedAI Offers Comprehensive Solutions for Drug Research and Development, Medical Imaging and Medical Therapy and Research System

BOC Sciences Completed Deployment of GMP Manufacturing Facilities to Promote Drug R&D

Shimmer Adopts the V3 Framework to Validate its Verisense® Wearable Sensing Platform for Clinical Trials

The Verisense IMU (inertial measurement unit) was the first Shimmer sensor validated following the V3 framework championed by the Digital Medicine Society (DiMe).

Samsung Biologics Issues Its First Annual Sustainability Report

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), published its first annual sustainability report, consolidating the company’s policies for an enhanced ESG management system and related plans. The report focuses on the company’s commitment to taking part in social responsibility over the past decade and its future plans for the next ten years and beyond.

Watson-Marlow Fluid Technology Group wins Best Business Award

Watson-Marlow Fluid Technology Group announces it has been named winner of the Best Employer category at the 2021 Best Business Awards.

BRIM Biotechnology’s lead candidate BRM421 for Dry Eye Syndrome shows promising results in Phase II clinical trials

BRIM Biotechnology, Inc. is pleased to advise that the Type C meeting with the US Food and Drug Administration (FDA) for the further development of lead candidate BRM421 for Dry Eye Syndrome (DES) has taken place, and preparation to initiate Phase III trials in 2022, is underway.

Optibrium Publishes Major Peer-Reviewed Study on AI Applications to Global Pharma Data

Published in AI Letters, the study collaborators Optibrium, Takeda and Intellegens, demonstrated the application of deep learning imputation to a global pharma dataset, offering new insights into drug discovery data that transform how complex data can be used to identify opportunities for new drugs and streamline the drug discovery process.

CyncHealth Selects Lyniate to Support Rapid Growth and Community Collaboration 

Lyniate announces that it has been selected by CyncHealth to support its explosive growth throughout the Midwest.

CluePoints’ Launch Post-COVID Trial Assurance Solution

CluePoints, the premier provider of Risk-Based Quality Management Solutions for clinical trials, has launched a new Post-COVID Trial Assurance Solution as part of its mission to build safer, more efficient trials for patients, sponsors and CROs.

Bio-Gate and Avicanna complete first phase of development on CBD and Micro Silver BG™ based skin care products for global commercialization

About Bio-Gate: Bio-Gate AG is one of the world’s leading providers of innovative technologies and customised solutions for health and hygiene. Our aim is to make living together safer and healthier and to improve the well-being of all individuals. Bio-Gate enhances materials and products with its technologies and antimicrobial and antiviral strategies, and, thereby improves the quality of life of people and animals alike. The company specializes in equipping materials and surfaces with antiviral and antimicrobial properties. Bio-Gate AG enhances materials and products, particularly in the field of medical technology, such as the coating of implants or wound dressings. In addition, Bio-Gate technologies are used to provide consumer, industrial and hygiene products, such as paints, coatings, plastics or protective film sprays with antiviral and antimicrobial properties, thus enhancing them in a unique way. Bio-Gate also uses its unique and multi-functional additive MicroSilver BG in dermatology and cosmetics as well as wound care to provide these kind of products with long-lasting antimicrobial, anti-inflammatory and Microbiome friendly properties.